Core Scientific Inc

Given the Bearish Exhaustion inflection and oversold backdrop, CORZ is positioned for a mean-reversion bounce. Short-term price has reclaimed and is holding above the 9- and 20-period EMAs within the support zone, offering a favorable entry point. Medium-term bias flips bullish under mean-reversion eligibility, while long-term trend remains down, framing this as a tactical rebound. Key risks include failure to sustain above EMA support and re-test of the lower support range.

• ↑Polaris DS acquisition adds 440 MW capacity, targeting 590 MW by 2027
• ↑Liquidity of ~$1.8B funds capex and strategic site builds
• ↓P/E of 841.7x and negative earnings yield imply overvaluation risks